Project Grant K23AA033457
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $189K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Denver, CO 80204, USA
Similar Awards
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Colorado-Denver $191,592 on August 19, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a five-year mentored research project on enhancing emergency department care for alcohol use disorder. Dr. Jacob Lebin will develop and test an electronic health record-embedded clinical decision support tool designed to improve identification and treatment of alcohol use disorder in emergency department...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Colorado-Denver $189,532 on August 19, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and test a peer-narrated video decision aid for alcohol treatment tailored to intensive care unit survivors with alcohol use disorder. The award funds a five-year career development project (K23) led by Dr. Kelsey Hills-Dunlap. The research addresses a gap identified in prior work: ICU survivors with alcohol use...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents Of The University Of Colorado (doing business as University Of Colorado-Denver) $191,509 on August 20, 2026, under the Alcohol Research Programs (CFDA 93.273) to adapt and pilot test a care navigation intervention for hospitalized patients with alcohol use disorder. The award funds adaptation and pilot testing of the Navigation for Prioritized Alcohol Treatment After Hospitalization (NAVPATH) intervention, which...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $3.23 million Project Grant to The Regents of the University of Colorado (University of Colorado-Denver) on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273). This four-year research project, concluding August 31, 2029, will investigate the effects of full-spectrum cannabidiol (CBD) on alcohol consumption and alcohol use disorder (AUD) phenotypes to inform precision medicine approaches. The research...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Trustees of the University of Pennsylvania $796,391 on June 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate how exogenous ketone supplementation modulates brain biochemistry and behavioral responses to alcohol in healthy adult drinkers. The research, designated R33AA031088, builds on prior R21 findings demonstrating that 25-gram ketone supplementation significantly reduced breath and blood alcohol...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $140,340 on December 1, 2025, under the Alcohol Research Programs (CFDA 93.273) for a Project Grant investigating the role of the C5 complosome in ethanol-induced immunometabolic dysregulation of Kupffer cells in alcohol-associated liver disease. The funded research defines novel mechanisms of alcohol-induced metabolic reprogramming of Kupffer...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Johns Hopkins University $672,377 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a clinical trial assessing cannabidiol as an adjunct treatment for alcohol withdrawal and craving in patients with alcohol use disorder. The study recruits individuals with moderate-to-severe alcohol use disorder for a four-day inpatient investigation where participants are randomized to receive placebo solution...
- The National Institute on Alcohol Abuse and Alcoholism awarded Palo Alto Veterans Institute For Research $1,091,712 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct a randomized, double-blind, sham-controlled trial assessing deep transcranial magnetic stimulation (DTMS) as a treatment for alcohol use disorder. The research enrolls 100 adults with alcohol use disorder into a mechanistic trial evaluating whether active DTMS targeting the medial prefrontal...
- The National Institute on Alcohol Abuse and Alcoholism awarded Kaiser Foundation Hospitals $759,219 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct early identification research on alcohol-associated liver disease in primary care settings. Kaiser Foundation Hospitals, through its Kaiser Foundation Research Institute division, will recruit 1,300 patients to determine the prevalence of current liver disease using transient elastography across all AUDIT-C...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $587,958 on August 10, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct a longitudinal sibling-comparison study of alcohol use disorder and co-occurring externalizing problems in high-risk individuals. The research follows 559 mid-adulthood participants with high prevalence of alcohol use disorder (67%), arrest history for...